摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-cyclopropyl-1H-indazole | 1426420-98-5

中文名称
——
中文别名
——
英文名称
6-cyclopropyl-1H-indazole
英文别名
——
6-cyclopropyl-1H-indazole化学式
CAS
1426420-98-5
化学式
C10H10N2
mdl
——
分子量
158.203
InChiKey
SYZUUZKFYUZDTD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    28.7
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-cyclopropyl-1H-indazole 、 potassium hydroxide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 3.0h, 以80%的产率得到6-cyclopropyl-3-iodo-1H-indazole
    参考文献:
    名称:
    [EN] ARYLOXYACETYLINDOLES AND ANALOGS AS ANTIBIOTIC TOLERANCE INHIBITORS
    [FR] ARYLOXYACÉTYLINDOLES ET ANALOGUES EN TANT QU'INHIBITEURS DE TOLÉRANCE AUX ANTIBIOTIQUES
    摘要:
    该披露提供了芳基氧乙酰基吲哚化合物及类似物的化合物和药物组合物,用于治疗慢性和急性细菌感染。其中某些化合物是一般式(I)(I)的化合物或其药用可接受的盐或前药。该披露的某些化合物是MvfR抑制剂。MvfR抑制剂减少抗生素耐药细菌菌株的形成,对治疗革兰氏阴性细菌感染和减少铜绿假单胞菌的毒力有用。该披露还提供了治疗受试者细菌感染的方法,包括铜绿假单胞菌感染。
    公开号:
    WO2016112088A1
  • 作为产物:
    描述:
    6-溴吲唑potassium phosphate 、 palladium diacetate 、 sodium hydride 、 三氟乙酸 作用下, 以 二氯甲烷N,N-二甲基甲酰胺甲苯 、 mineral oil 为溶剂, 反应 3.25h, 生成 6-cyclopropyl-1H-indazole
    参考文献:
    名称:
    [EN] PYRROLOPYRAZINE KINASE INHIBITORS
    [FR] INHIBITEURS DE PYRROLOPYRAZINE KINASE
    摘要:
    本发明涉及式I的新型吡咯并吡嗪衍生物的使用,其中变量如本文所述定义,其抑制JAK和SYK,并可用于治疗自身免疫和炎症性疾病。
    公开号:
    WO2013030138A1
点击查看最新优质反应信息

文献信息

  • Pyrrolopyrazine kinase inhibitors
    申请人:Chen Shaoqing
    公开号:US08658646B2
    公开(公告)日:2014-02-25
    The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
    本发明涉及使用式I中新型吡咯吡嗪生物,其中变量如本文所述,其抑制JAK和SYK并且用于治疗自身免疫和炎症性疾病。
  • PYRROLOPYRAZINE KINASE INHIBITORS
    申请人:Chen Shaoqing
    公开号:US20130059834A1
    公开(公告)日:2013-03-07
    The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
    本发明涉及使用新型吡咯吡嗪生物(式I)的使用,其中变量如此处所述,其抑制JAK和SYK并且适用于治疗自身免疫和炎症性疾病。
  • Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome
    作者:Stephen M. Lynch、Javier DeVicente、Johannes C. Hermann、Saul Jaime-Figueroa、Sue Jin、Andreas Kuglstatter、Hongju Li、Allen Lovey、John Menke、Linghao Niu、Vaishali Patel、Douglas Roy、Michael Soth、Sandra Steiner、Parcharee Tivitmahaisoon、Minh Diem Vu、Calvin Yee
    DOI:10.1016/j.bmcl.2013.02.012
    日期:2013.5
    Using a structure based design approach we have identified a series of indazole substituted pyrrolopyrazines, which are potent inhibitors of JAK3. Intramolecular electronic repulsion was used as a strategy to induce a strong conformational bias within the ligand. Compounds bearing this conformation participated in a favorable hydrophobic interaction with a cysteine residue in the JAK3 binding pocket, which imparted high selectivity versus the kinome and improved selectivity within the JAK family. (C) 2013 Published by Elsevier Ltd.
  • Design, synthesis and structure–activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK)
    作者:Xueying Wang、Gang Xue、Zhengying Pan
    DOI:10.1016/j.ejmech.2019.111918
    日期:2020.2
    Interleukin-2 inducible T-cell kinase (ITK), a member of the Tec family of tyrosine kinases, plays an important role in T cell signaling downstream of the T-cell receptor (TCR). Herein we report the discovery of a series of indolylindazole based covalent ITK inhibitors with nanomolar inhibitory potency against ITK, good kinase selectivity and potent inhibition of the phosphorylation of PLC gamma l and ERK1/2 in living cells. A computational study provided insight into the interactions between inhibitors and Phe437 at the ATP binding pocket of ITK, suggesting that both edge-to-face pi-pi interaction and the dihedral torsion angle contribute to inhibitors' potency. Compounds 43 and 55 stood out as selective covalent inhibitors with potent cellular activity, which could be used as chemical tools for further study of ITK functions. (C) 2019 Elsevier Masson SAS. All rights reserved.
  • US8658646B2
    申请人:——
    公开号:US8658646B2
    公开(公告)日:2014-02-25
查看更多